Current Rating and Its Significance
MarketsMOJO’s 'Buy' rating for Artemis Medicare Services Ltd indicates a positive outlook on the stock, suggesting that investors may consider adding it to their portfolios. This recommendation is based on a comprehensive evaluation of the company’s quality, valuation, financial trend, and technical indicators. The rating was revised on 8 June 2026, reflecting an improvement in the company’s overall mojo score from 61 to 71, signalling stronger fundamentals and market positioning.
Quality Assessment
As of 10 June 2026, Artemis Medicare Services Ltd demonstrates a solid quality grade, reflecting its operational strength and financial health. The company has maintained positive results for nine consecutive quarters, underscoring consistent performance. Its operating profit has grown at an impressive annual rate of 59.20%, highlighting robust business expansion and efficient cost management. Furthermore, the company’s ability to service debt is strong, with a low Debt to EBITDA ratio of 1.39 times, indicating manageable leverage and financial stability.
Valuation Perspective
The valuation grade for Artemis Medicare Services Ltd is currently attractive. The stock trades at a Price to Book Value of 4.4, which is considered reasonable within its sector. Compared to its peers, the stock is trading at a discount relative to historical valuations, offering potential value for investors. Despite a one-year return of -2.04%, the company’s profits have increased by 28.2% over the same period, suggesting that the market may not have fully priced in the company’s earnings growth. The PEG ratio stands at 3.4, indicating a moderate premium for growth prospects.
Financial Trend Analysis
Financially, Artemis Medicare Services Ltd is on a positive trajectory. The company’s quarterly net sales reached a high of ₹279.23 crores, while PBDIT (Profit Before Depreciation, Interest, and Taxes) peaked at ₹51.60 crores, both marking record levels. The operating profit to interest ratio is strong at 8.10 times, reflecting efficient interest coverage and operational profitability. Return on Equity (ROE) is currently 11.3%, which is a healthy indicator of shareholder returns and capital utilisation. These metrics collectively point to a company with improving financial health and sustainable growth potential.
Technical Outlook
From a technical standpoint, the stock exhibits a mildly bullish trend. Recent price movements show a modest 0.23% increase on the day, although the stock has experienced some volatility over the past weeks and months, including a 3.36% decline over the last week and a 5.61% drop over six months. However, the three-month return of +12.89% suggests a recovery phase and positive momentum. This technical profile supports the 'Buy' rating, indicating that the stock may be poised for further gains in the near term.
Stock Performance Summary
As of 10 June 2026, Artemis Medicare Services Ltd’s stock performance reflects mixed short-term trends but a favourable medium-term outlook. The year-to-date return stands at -4.34%, while the one-year return is slightly negative at -2.04%. Despite these modest declines, the company’s improving fundamentals and attractive valuation underpin the positive rating. Investors should consider these factors alongside broader market conditions when evaluating the stock.
Strong fundamentals, solid momentum, fair price – This Large Cap from the NBFC sector checks every box for our Top 1%. This should definitely be on your radar!
- - Complete fundamentals package
- - Technical momentum confirmed
- - Reasonable valuation entry
What This Rating Means for Investors
For investors, the 'Buy' rating on Artemis Medicare Services Ltd signals confidence in the company’s ability to deliver value over time. The combination of strong quality metrics, attractive valuation, positive financial trends, and supportive technical signals suggests that the stock is well-positioned for growth. Investors seeking exposure to the hospital sector with a focus on companies demonstrating operational resilience and growth potential may find Artemis Medicare Services Ltd a compelling option.
Considerations and Risks
While the outlook is positive, investors should remain mindful of the stock’s recent volatility and the broader market environment. The stock’s short-term returns have been mixed, and the PEG ratio of 3.4 indicates that some growth expectations are already priced in. Additionally, the company’s smallcap status may entail higher risk compared to larger, more established peers. Continuous monitoring of quarterly results and sector developments is advisable to ensure alignment with investment goals.
Conclusion
In summary, Artemis Medicare Services Ltd’s current 'Buy' rating by MarketsMOJO, updated on 8 June 2026, reflects a well-rounded assessment of the company’s strengths and prospects as of 10 June 2026. The stock’s quality, valuation, financial trend, and technical outlook collectively support a positive investment stance. Investors looking for growth opportunities in the hospital sector should consider this stock within the context of their portfolio strategy and risk tolerance.
Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today
